Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07773675

The Effect of an Integrated Mobile Health Platform on Early Detection of Clinical Outcomes of Critical Ill Patients

This study will aim to examine the Effect of integrated Mobile Health Platform on early detection of clinical outcomes of Critical ill patients.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Mobile Health Platform Clinical Outcomes

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sohag University Hospital, General Intensive Care Unit

Sohag, Sohag Governorate, Egypt

About this study

This study clarify if using if using the electric platform will reduce the complications in critical ill patients this complications include respiratory complications, renal complications, cardiac complications

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients aged 18-65 years.
  • Anticipated ICU stay of more than 24 hours.
  • Clinical requirement and ability to continuously monitor vital signs and urine output.
  • Obtained written informed consent from the patient or their legal guardians.

Exclusion criteria

  • Patients placed in strict isolation due to highly infectious diseases.
  • Death within 24 hours of ICU admission.
  • Patients transferred from another external Intensive Care Unit.
  • Re-admission to the ICU during the active study period.
  • Pre-existing chronic altered consciousness or irreversible neurological deficit.
  • Patients who underwent pre-hospital cardiopulmonary resuscitation (CPR).

Treatment and study plan

Integrated Mobile Health Platform

Device

A digital health platform integrated with ICU monitoring systems to automatically collect, record, and analyze patient vital signs and lab trends, generating real-time early warning alerts for healthcare providers.

Primary outcomes

  1. ICU Mortality Rate

    Time frame: From ICU admission up to 30 days.

    The percentage of critically ill patients who die in the General Intensive Care Unit during their hospital stay. This will evaluate the impact of the mHealth platform on reducing patient mortality.

Secondary outcomes

  1. ICU Length of Stay (LOS)

    Time frame: From ICU admission up to 30 days.

    The total number of days each patient spends in the General Intensive Care Unit from the day of admission until discharge.

  2. Incidence of Clinical Complications

    Time frame: Daily from study enrollment until ICU discharge, up to 30 days.

    The occurrence of organ-specific complications during the ICU stay, including respiratory (pulmonary edema, ARDS, pneumonia, difficult weaning), cardiac (cardiac arrest, shock, arrhythmia), and renal complications (acute renal failure).

Study contacts

Contact information is provided by the study sponsor or research team.

Asmaa Yassen, MSc

CONTACT

[email protected]

+201095196756

Mogedda Mehany, PhD

CONTACT

+201066645420

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Aug 19, 2026
Registry last updated
Aug 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.